U.S. vaccine policy could see big changes in 2026
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
FDA approves weight loss drug in daily pill form
FDA approves weight loss drug in daily pill form – CBS News Watch CBS News Regulators at the…
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
Approval of YARTEMLEA was based on results from a single-arm, open-label study in adults with TA-TMA (the TA-TMA…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
CDC grant goes to Danish researchers with ties to Tracy Beth Høeg
WASHINGTON — The Centers for Disease Control and Prevention has awarded a $1.6 million grant to controversial researchers at…
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals’ (AMPH) Narrative?
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide…
Female libido pill gets expanded approval for menopause by FDA
U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now…
Amphastar Announces FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the…
Local doctor’s office looking for people to participate in Lyme vaccine trial
A local doctor’s office is looking for people to be part of a Lyme vaccine trial. They reached…
Mutual mistrust: FDA staff wary as Høeg becomes top drug regulator
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…
Regulatory reform can unlock access to biosimilars
Every day, I think about the patients waiting for medicines that could change, or even save, their lives.…
Embattled FDA official defends vaccine plan in closed-door remarks
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing…